3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Genitourinary
1
Conditions
Prostatic Neoplasms
9
Prostatic Neoplasms, Castration-Resistant
6
Metastatic Castration-resistant Prostate Cancer
2
Pain
1
Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Fractures, Bone
1
Fatigue
1
Castration-resistant Prostate Cancer
1
Bony Metastases From Castrate Refractory Prostate Cancer
1
Bone Neoplasms
1
Bone Metastatic Castration-resistant Prostate Cancer
1
Advanced Prostate Cancer
1
Interventions
Observation
2
Curettage
2
radium Ra 223 dichloride
1
Weight-Bearing
1
Transplantation, Homologous
1
Transplantation, Autologous
1
Tomography, Spiral Computed
1
TES
1
Surveys and Questionnaires
1
Range of Motion, Articular
1
Radiomics
1
Quality of Life
1
Quality Assurance, Health Care
1
Polymethyl Methacrylate
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Microbiota
1
Methods
1
Metabolome
1
Magnetic Resonance Imaging
1
Interviews as Topic
1
Indocyanine Green
1
Immunotherapy
1
Histocompatibility Testing
1
Hematologic Tests
1
HMPL-013
1
Genetic Testing
1
Echocardiography
1
Drug Therapy
1
Diagnostic Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Bone Neoplasms
×
radium Ra 223 dichloride
×
Clear all
NCT04681144
2023-10-26
QOLRAD
Bayer
Completed
103 enrolled